GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 209 filers reported holding GENMAB A/S in Q1 2023. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6 | -14.3% | 172 | 0.0% | 0.00% | – |
| Q2 2023 | $7 | +16.7% | 172 | 0.0% | 0.00% | – |
| Q1 2023 | $6 | -14.3% | 172 | 0.0% | 0.00% | – |
| Q4 2022 | $7 | -99.8% | 172 | +25.5% | 0.00% | – |
| Q3 2022 | $4,000 | 0.0% | 137 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -20.0% | 137 | 0.0% | 0.00% | – |
| Q1 2022 | $5,000 | 0.0% | 137 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | -28.6% | 137 | -17.0% | 0.00% | – |
| Q3 2021 | $7,000 | +75.0% | 165 | +91.9% | 0.00% | – |
| Q2 2021 | $4,000 | +33.3% | 86 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | 0.0% | 86 | 0.0% | 0.00% | – |
| Q4 2020 | $3,000 | -57.1% | 86 | -55.9% | 0.00% | – |
| Q3 2020 | $7,000 | +75.0% | 195 | +14.0% | 0.00% | – |
| Q2 2020 | $4,000 | 0.0% | 171 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | 0.0% | 171 | 0.0% | 0.00% | – |
| Q4 2019 | $4,000 | – | 171 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $10,291,898 | 3.87% |
| Arlington Capital Management, Inc. | 26,115 | $1,106,754 | 1.24% |
| Dorsey Wright & Associates | 87,451 | $3,706,173 | 1.08% |
| Hardman Johnston Global Advisors LLC | 604,982 | $25,639,137 | 1.00% |
| TORRAY INVESTMENT PARTNERS LLC | 128,564 | $5,448,542 | 0.98% |
| Yorktown Management & Research Co Inc | 16,600 | $703,508 | 0.86% |
| First Light Asset Management, LLC | 160,263 | $6,791,946 | 0.63% |
| KLR INVESTMENT ADVISORS, LLC | 12,604 | $534,158 | 0.44% |
| Campbell & CO Investment Adviser LLC | 42,851 | $1,816,025 | 0.43% |
| Integrated Investment Consultants, LLC | 15,946 | $675,791 | 0.23% |